News

In 2023, a report by Lord James O’Shaughnessy found the UK had dropped from fourth to tenth as global contributors to ...
Discover how generative AI is revolutionising clinical trials, from enhancing patient recruitment to improving data analysis.
Partnership includes training program for medical students, focused on how to analyze clinical trial diversity data ATLANTA, GA – MARCH 31, 2025 – Morehouse School of Medicine (MSM) and the Catalyzing ...
The first-ever analysis of the UK clinical trial landscape by the Medicines and Healthcare products Regulatory Agency (MHRA) ...
The agency is still unclear about where it will stand on clinical trial diversity, but companies are looking for answers and ...
Is clinical trial representation fair? Learn why disease incidence matters more than Census data for health equity.
LaShell Robinson, head of global feasibility and trial equity at Takeda, talks about Takeda's aims to expand its efforts globally by adapting strategies to regional needs.
Discover how Temple Lung Center’s innovative clinical trials provide early access to breakthrough treatments and enhanced ...
In this video interview, Craig Lipset, co-chair, Decentralized Trials & Research Alliance (DTRA), discusses how the current political climate is affecting diversity in clinical research and how ...
Clinical researcher Nadine Spring discusses the long-standing lack of diversity in clinical trials and why she's fighting for ...
A systematic review of randomized clinical trials (RCTs ... A geographic analysis showed no trial sites in Africa or South/Central America, with most trials conducted in North America.
The removal of the FDA’s draft guidance on clinical trial diversity from the agency’s website, followed by its reappearance — with a note that the agency and administration “reject” it ...